申请人:Merck & Co., Inc.
公开号:US05264420A1
公开(公告)日:1993-11-23
Fibrinogen receptor antagonists of the formula: ##STR1## are disclosed for use in inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.
本发明揭示了一种公式为:##STR1##的纤维蛋白原受体拮抗剂,用于抑制纤维蛋白原与血小板的结合以及抑制血小板的聚集。